Business Description
Guobang Pharma Ltd
ISIN : CNE100004NS2
Share Class Description:
SHSE:605507: Class ACompare
Compare
Traded in other countries / regions
605507.China IPO Date
2021-08-02Description
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.38 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 1.1 | |||||
| Interest Coverage | 32.1 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.12 | |||||
| Beneish M-Score | -1.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.7 | |||||
| 3-Year EBITDA Growth Rate | -8 | |||||
| 3-Year EPS without NRI Growth Rate | -15.2 | |||||
| 3-Year Book Growth Rate | 24.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.76 | |||||
| 9-Day RSI | 54.89 | |||||
| 14-Day RSI | 52.67 | |||||
| 6-1 Month Momentum % | 28.83 | |||||
| 12-1 Month Momentum % | 26.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.21 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.84 | |||||
| Days Inventory | 115.49 | |||||
| Days Sales Outstanding | 43.23 | |||||
| Days Payable | 125.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.43 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| Forward Dividend Yield % | 1.43 | |||||
| 5-Year Yield-on-Cost % | 1.43 | |||||
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | -0.31 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.66 | |||||
| Operating Margin % | 14.62 | |||||
| Net Margin % | 12.29 | |||||
| FCF Margin % | 1.09 | |||||
| ROE % | 9.3 | |||||
| ROA % | 6.85 | |||||
| ROIC % | 11.5 | |||||
| ROC (Joel Greenblatt) % | 15.71 | |||||
| ROCE % | 10.42 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.68 | |||||
| Forward PE Ratio | 9.87 | |||||
| PE Ratio without NRI | 15.64 | |||||
| Price-to-Owner-Earnings | 64.71 | |||||
| PS Ratio | 2.05 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.57 | |||||
| Price-to-Free-Cash-Flow | 206.17 | |||||
| Price-to-Operating-Cash-Flow | 21.95 | |||||
| EV-to-EBIT | 12.44 | |||||
| EV-to-EBITDA | 12.44 | |||||
| EV-to-Revenue | 1.8 | |||||
| EV-to-FCF | 167.05 | |||||
| Price-to-Graham-Number | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 4.1 | |||||
| Earnings Yield (Greenblatt) % | 8.04 | |||||
| FCF Yield % | 0.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guobang Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,714.118 | ||
| EPS (TTM) (Â¥) | 1.26 | ||
| Beta | 0.64 | ||
| Volatility % | 34.94 | ||
| 14-Day RSI | 52.67 | ||
| 14-Day ATR (Â¥) | 0.4681 | ||
| 20-Day SMA (Â¥) | 20.9885 | ||
| 12-1 Month Momentum % | 26.64 | ||
| 52-Week Range (Â¥) | 13.01 - 23.09 | ||
| Shares Outstanding (Mil) | 558.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guobang Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guobang Pharma Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guobang Pharma Ltd Frequently Asked Questions
What is Guobang Pharma Ltd(SHSE:605507)'s stock price today?
The current price of SHSE:605507 is ¥21.02. The 52 week high of SHSE:605507 is ¥23.09 and 52 week low is ¥13.01.
When is next earnings date of Guobang Pharma Ltd(SHSE:605507)?
The next earnings date of Guobang Pharma Ltd(SHSE:605507) is .
Does Guobang Pharma Ltd(SHSE:605507) pay dividends? If so, how much?
The Dividend Yield %  of Guobang Pharma Ltd(SHSE:605507) is 1.43% (As of Today), Highest Dividend Payout Ratio of Guobang Pharma Ltd(SHSE:605507) was 0.57. The lowest was 0.12. And the median was 0.37. The  Forward Dividend Yield % of Guobang Pharma Ltd(SHSE:605507) is 1.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers